7 slides, 1080×1350. Make PNGs and a carousel PDF with npm run reports:cards -- 2026-11-22/sector-snapshot/health-bio.Back to the report
Health & Biotech companies raised $20.9B in equity in 2025–2026, 3.1% of all tracked capital, and 2026 has already passed 2025 ($12.6B against $8.4B).
Isomorphic Labs leads with $2.7B, 13% of the sector's equity in 2025–2026.
The biggest single round was Isomorphic Labs' $2.1B Series B on 12 May 2026, led by Thrive Capital.
Series C to E rounds took 34% of the equity; the median round there was $287M.
T. Rowe Price backed 8 Health companies in 2025–2026. For RA Capital Management the sector is 100% of its tracked portfolio.
ARCH Venture Partners and T. Rowe Price invested together in 5 Health rounds, across Kardigan, Mirador Therapeutics, Ollin Biosciences and 1 other.
Every round, valuation and investor of Health & Biotech, on the globe.
vcwithin.com/reports/2026-11-22/sector-snapshot/health-bio
A company and a sector every day · sources on every page